News News Releases Martin Lehr 9/19/19 News Releases Martin Lehr 9/19/19 Context Therapeutics and Thomas Jefferson University to Evaluate Apristor Combination Therapy for Women with Advanced Endometrial Cancer Read More News Releases Martin Lehr 9/16/19 News Releases Martin Lehr 9/16/19 Context Therapeutics and SOLTI launch ONAWA: a Window of Opportunity Study in Breast Cancer with Apristor Read More News Releases Martin Lehr 4/30/19 News Releases Martin Lehr 4/30/19 Context Therapeutics and Memorial Sloan Kettering Cancer Center Announce a Phase 2 Basket Trial for Apristor in PR+ Gynecological Cancers Read More Newer Posts Older Posts
News Releases Martin Lehr 9/19/19 News Releases Martin Lehr 9/19/19 Context Therapeutics and Thomas Jefferson University to Evaluate Apristor Combination Therapy for Women with Advanced Endometrial Cancer Read More
News Releases Martin Lehr 9/16/19 News Releases Martin Lehr 9/16/19 Context Therapeutics and SOLTI launch ONAWA: a Window of Opportunity Study in Breast Cancer with Apristor Read More
News Releases Martin Lehr 4/30/19 News Releases Martin Lehr 4/30/19 Context Therapeutics and Memorial Sloan Kettering Cancer Center Announce a Phase 2 Basket Trial for Apristor in PR+ Gynecological Cancers Read More
